EHPnet: National Institute of Neurological Disorders and Stroke by Dooley, Erin E.
Marine Toxin
Hinders Cognitive
Development
Domoic acid, a naturally occurring marine
toxin, causes acute symptoms of diarrhea,
vomiting, seizures, and memory loss in
people sickened by eating contaminated
shellfish. Now a recent study reveals that
exposure to even tiny amounts of domoic
acid in utero may produce subtle, long-term
cognitive impairment in rats. The new
findings raise the possibility that pregnant
women who inadvertently eat shellfish
tainted with low levels of domoic acid may
put their unborn children at risk for life-
long behavioral consequences, says Edward
D. Levin, a professor of psychiatry at Duke
University Medical Center in Durham,
North Carolina. Levin coauthored the
study, which is described in the September/
October 2005 issue of Neurotoxicology and
Teratology.
Harmful algal blooms that
produce domoic acid are
increasing, possibly due to
warming ocean waters and
human impacts such as farm
and sewage runoff. Shellfish
take in the toxin when they
filter water and incorporate it
into their tissues. Along the
Florida coast, pigments in the
“red tides” caused by Karenia
brevis and other dinoflagel-
lates signal toxic blooms.
However, no distinctive color
characterizes toxic blooms
elsewhere, such as those
along the Oregon coast
caused by Pseudonitzschia, a
phytoplankton that generates
domoic acid. “The first warn-
ing sign we get for these toxic
blooms is when domoic acid
shows up in routine testing of
shellfish,” says Peter Strutton,
a biological oceanographer at
Oregon State University in
Corvallis. Thus, it’s possible
that shellfish with potentially
dangerous levels of domoic
acid are being harvested and
consumed (Strutton notes that, in Oregon
at least, most of the shellfish of concern are
those that people catch recreationally on
their own).
In the Levin study, the researchers
injected pregnant rats with single doses of
0.3, 0.6, or 1.2 milligrams of domoic acid
per kilogram body weight at the end of the
second trimester. The highest dose was in
the low end of the range known to cause
acute illness in rats. 
During adolescence and adulthood, the
offspring underwent a battery of behavioral
tests. In a radial-arm maze, which looks like
a wagon wheel without its rim, the rats
searched for sugary cereal at the ends of
arms extending from a central hub. Once
eaten, the cereal is not replaced, and the
rats must remember which arms they’ve
already explored. This test therefore meas-
ures working memory. The females per-
formed the same regardless of dose, while
the males performed progressively worse as
the dose increased (male rats normally per-
form better than females in this maze). 
Next Levin gave the rats low doses of
scopolamine, a drug that causes amnesia
and memory impairment. Slightly stress-
ing the brain with a low dose of scopo-
lamine helped to uncover subtle neurolog-
ical defects caused by domoic acid.
Compared to controls, rats exposed to
domoic acid had greater memory loss fol-
lowing administration of scopolamine,
with the highest-dose group performing
the worst. “Animals can normally deal with
a low dose of scopolamine,” says Levin,
“unless there’s prior neurotoxic damage
that adversely affects the brain.” 
Now researchers wonder whether
domoic acid may negatively affect unborn
children even at levels that do not cause
symptoms in expectant mothers. The
U.S. Food and Drug Administration
based its current limits for domoic acid in
shellfish on levels that are assumed to be
safe for adults. “We may need to re-eval-
uate the monitoring of waters and
seafood to make sure that the most sensi-
tive members of the population are pro-
tected from toxic exposure to domoic
acid,” says Levin. However, he adds, it’s
important to ensure that fisherman are
not unnecessarily cut off from their liveli-
hood and that people are not
deprived of the nutritional
benefits of uncontaminated
seafood. 
Strutton and Michelle
Wood at the University of
Oregon in Eugene are develop-
ing a new tool to improve early
surveillance of toxic blooms.
They are combining satellite
data on physical attributes of
the ocean such as water color
and surface temperature to
identify early markers for toxic
blooms. In collaboration with
the National Oceanic and
Atmospheric Administration’s
CoastWatch program, they
plan to develop products for
coastal managers such as charts
of conditions that raise the risk
of domoic acid poisoning of
shellfish. CoastWatch also
plans to post satellite maps of
regions where blooms exist or
are developing on its website.
“It will warn [managers] to
ramp up their shoreline
sampling of shellfish beds,”
Strutton says. –Carol Potera
NEUROLOGY
If the brain were so simple we could understand it, we would be so simple we couldn’t.  
Lyall Watson, philosopher
Environews Forum
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c A meal for mothers to skip? New studies in rats show that the marine toxin
domoic acid may impair fetal cognitive development when mothers consume
contaminated shellfish.Back-Door Cigarette
Marketing?
At a time when marketing restrictions make it
harder for tobacco manufacturers to reach the
youth market, a number of new candy- and
liqueur-flavored tobacco products are hitting
the market. A review of internal tobacco
industry documents published in the
November/December 2005 issue of
Health Affairs showed that the
industry has long sought to
target youth through new
flavors, with one document
stating that young people’s
interest in unusual flavors “may
indicate new opportunities for
enhanced-flavor tobacco products that
could leverage [brand’s] current strength
among younger adult smokers.” The authors
write that flavored cigarettes can promote youth
smoking initiation and help young occasional
smokers become daily smokers by reducing or
masking the unpleasant taste of tobacco smoke.
The authors add there is little information on the
potential health effects of the flavorings
themselves.
In My Skin
Rates of melanoma, the deadliest skin cancer,
continue to climb, more than tripling in
Caucasians between 1980 and 2002, according to
the American Cancer Society. Now skin cancer
experts at the University of Newcastle upon Tyne
have developed a novel test that uses a small skin
sample and responses to a ten-page questionnaire
to produce highly personalized assessments of the
risks individuals face from their sun exposure to
date. Patients also receive personalized skin
protection advice and can re-take the test to see
how changes they’ve made have affected their
skin cancer risk. The “skinphysical” test was
launched at British clinics in the autumn of 2005. 
The Healing Quiet
A new study from The Johns Hopkins University
shows that a noisy hospital environment may
make patients sicker and lead to higher stress
levels and burnout
among staff. The study,
presented at the 2005
annual meeting of the
Acoustical Society of
America, found that
hospital noise levels
worldwide have grown
steadily over the past five
decades and now on
average exceed WHO
hospital noise guidelines.
This disturbs those within
the hospital’s confines,
raises the risk of medical errors, and can even
slow the pace of healing and contribute to lapses
in short-term memory. Two possible solutions are
to equip hospital personnel with hands-free
personal communicators (eliminating the need for
loudspeakers) and to wrap fiberglass insulation
with an antibacterial fabric to form a sound-
absorbent tile for ceilings and walls.
Forum
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Cloud Banks: 
Airlines Save Halon
The airlines of the developing world are
being advised by the United Nations
Environment Programme (UNEP) to
bank their stocks of halons—chemicals
vital for extinguishing aircraft fires—as the
2010 deadline to cease production
approaches. Most devel-
oped nations already have
plans for halon recycling
and banking systems—
registries of who has excess
halon to sell. For develop-
ing countries, however,
the challenges of starting
up such systems may leave
some airlines grounded.
Halons have been used
for years in many kinds of
fire-extinguishing systems.
However, when they escape
into the atmosphere, UV
light causes them to release
highly reactive bromine
radicals that deplete the
ozone layer. Indeed, halons
are thought to be three to
ten times more ozone-
unfriendly than chloroflu-
orocarbons. For this reason the Montréal
Protocol obliged developed nations to cease
halon production in 1994, and set a 2010
target date for the developing world.
The trouble is that, while replacements
for halons now exist for nearly all other
applications, these chemicals remain essen-
tial for aircraft safety. Jim Curlin, informa-
tion manager of the UNEP Division of
Technology Industry and Economics,
OzonAction Branch, explains, “Aircraft
fire-extinguishing systems must have good
dispersion and fire-suppression functions,
must work at low temperatures, be of low
toxicity to humans for the time that they
are trapped in an affected plane and have
an excellent weight-to-volume ratio.”
Currently, he says, there is no drop-in
replacement for halons that has all these
characteristics, making halon availability
critical to airlines.
Even developed countries are not with-
out halon banking problems. Developed
nations have enough halon 1301—which is
used in cargo bay and engine fire-fighting
equipment—to last some 25 years, by which
time a replacement should be available,
explains John O’Sullivan, a member of the
UNEP Halons Technical Options Com-
mittee and fire representative for the
International Air Transport Association in
Montréal. But there isn’t enough halon
1211, which is used by aircrew in handheld
extinguishers. “[Halon 1211] can still be
made in developing countries, so at least in
this respect [developing nations] should have
fewer problems,” says O’Sullivan. “But
European regulations, for example, make it
difficult to import. This is a problem we still
have to address.”
Starting up halon banking systems is
certainly in the best inter-
est of developing world
airlines. With passenger
safety a top priority, air-
craft that do not maintain
their halon-based systems
would eventually fail air-
worthiness inspections and
be banned from flying to
many destinations. But
how easy will it be for
developing countries to
start such systems, and
where does halon banking
figure on their priority list? 
“Most focus first on
economic problems and
then on the environment,”
says Wilman Rajiman,
the Indonesia Halon
Bank Project manager at
Soekarno-Hatta Internat-
ional Airport in Jakarta. “In Indonesia we
started to discuss a national halon bank in
1995, but due to an economic crisis in
1998 it was not launched until March
2000. The major problems we faced were
capital investment, knowledge, training,
and local regulations.” 
For many countries, cash flow will be
the major obstacle. Rajiman explains that
Indonesia received a grant from the World
Bank, but must spend its own money and
then ask for reimbursement. Poorer nations
may find that stipulation difficult, yet air-
line-servicing companies worldwide must
comply strictly with the halon specifica-
tions laid down by aircraft manufacturers
and foreign aviation authorities. Main-
taining proper halon stocks is therefore
vital to their business. 
Flyers may be comforted to know that
the Montréal Protocol contains a clause that
allows developing nations to temporarily
restart halon production for critical systems
if supplies fail—always supposing the neces-
sary infrastructure exists. “That’s a situation
we all want to avoid,” says Curlin, “and one
of the reasons we are encouraging compa-
nies and countries to develop halon banks.”
–Adrian Burton
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POLICY
Fear of firing. Halon, used to put out
fires on aircraft, is being phased out
with no suitable replacement in sight. A 96 VOLUME 114 | NUMBER 2 | February 2006 • Environmental Health Perspectives
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Expanding the
Medicine Chest
About 10% of the asthmatic population has
a severe form of the disease that can require
progressively higher doses of corticosteroid
drugs to manage the symptoms. Now a new
therapeutic approach, described in the
December 2005 issue of Thorax, may help
people whose severe asthma symptoms no
longer respond to steroid treatments. 
Early research suggested that asthma
was a so-called Th2 cytokine disorder
involving certain white blood cells known
as eosinophils. However, Stephen T.
Holgate, a professor in the Infection,
Inflammation, and Repair Division of
Southampton General Hospital in the
United Kingdom, and other researchers
noticed that severe asthma was actually
associated with neutrophils, another type of
white blood cell that is associated with Th1
diseases such as rheumatoid arthritis and
psoriasis. These diseases respond well to
treatments that block the action of an
immune system molecule called tumor
necrosis factor–alpha (TNF-α). If severe
asthma was truly a Th1 disease, Holgate
hypothesized, it stood to reason that it too
would respond to a TNF-α blocker. 
To test this idea, Holgate and his col-
leagues administered the drug etanercept
(Enbrel®) to 17 subjects with severe asthma
in a 12-week study. Etanercept is a soluble
receptor that binds to TNF-α. Treatment
was associated with significant improve-
ments in asthma symptoms and lung func-
tion, and reduction of bronchial hyper-
responsiveness (abnormal sensitivity to
agents that narrow the airways) in the 15
patients who completed the regimen.
Some research now suggests that asthma
is not a single disease. “Mild and moderate
forms of asthma may be disorders primarily
characterized by a Th2-type immune
response associated with allergen-specific
IgE antibodies,” Holgate says. “In contrast,
severe asthma, which is aggravated by virus-
es and air pollution, may be a separate Th1-
type immune disorder that involves the
excess production of TNF-α.” This could
explain why the use of etanercept in previ-
ous studies of mild asthma produced no
improvement in symptoms.
Although the improvement in asthma
symptoms and airway hyperresponsiveness
are impressive, placebo-controlled studies
are needed to assess the efficacy of anti-
TNF-α therapy. According to Holgate,
such studies are now under way in his and
other laboratories, and the preliminary
results look quite promising. “In twenty-
seven years of asthma research, this is the
biggest breakthrough that [our research
group has] had,” he says. –Michael Szpir
PD Gene and Oxidative Stress
A gene linked to familial Parkinson disease (PD) may protect neurons
from oxidative damage, according to two independent studies in the
fruit fly Drosophila. Flies lacking the DJ-1 gene showed selective sen-
sitivity to widely used agricultural toxicants that kill neurons mainly
through oxidative stress. The studies, published 6 September 2005 in
Current Biology, suggest that normally “DJ-1 has a neuroprotective
role against different oxidative stimuli,” says Darren Moore, an
instructor in neurology at the Johns Hopkins University School of
Medicine who has studied the gene. However, if DJ-1 stops work-
ing—because of either an inherited mutation or toxicant exposure—
oxidative stress may wreak havoc on the brain, killing dopamine-
producing neurons.
Experiments in cultured cells and in knockout mice have hinted
that  DJ-1 mutations may sensitize cells to the harmful effects of
oxidative stress. This type of oxidative damage happens when unsta-
ble oxygen molecules react with certain components inside cells in a
manner similar to the process that converts iron to rust. Many envi-
ronmental insults—including exposure to certain agricultural chem-
icals—can generate these unstable oxygen molecules.
To pin down how DJ-1 interacts with such oxidative stress agents,
Nancy Bonini, a professor of biology at the University of
Pennsylvania, Philadelphia, and her colleagues first identified DJ-1 in
Drosophila, which they found exists in two forms: DJ-1α (expressed
primarily in the testes) and DJ-1β (expressed everywhere). They then
created a line of Drosophila mutants completely lacking both forms. 
The flies with no DJ-1 had normal life spans and showed no neu-
ronal degeneration. However, when Bonini and her colleagues
exposed flies to the herbicide paraquat, DJ-1 mutants died much
sooner than normal flies. The mutants also showed marked sensitivi-
ty to the insecticide rotenone and to hydrogen peroxide—both agents
that promote oxidative stress. These results suggest that DJ-1 nor-
mally protects against oxidative stress and that its inactivation may
leave neurons susceptible to oxidative damage. The team also found
that exposure to paraquat led to biochemical modification of the DJ-
1β protein, a change Bonini says may somehow influence the ability
of DJ-1 to protect neurons from oxidative damage. 
In the other paper, Kyung-Tai Min, an investigator at the
National Institute of Neurological Disorders and Stroke, and his col-
leagues examined a different type of Drosophila DJ-1 mutant. They
disrupted the function of DJ-1β by inserting a mutation into the
middle of the gene. Surprisingly, Min says, they found that dopamin-
ergic neurons in these mutants survived longer into old age than did
neurons of normal flies. They also found that their DJ-1β mutants
were much more resistant to paraquat insult than were normal flies.
Further examination revealed that these flies had elevated DJ-1α
expression—the loss of DJ-1β somehow encouraged a compensatory
upregulation of DJ-1α, which the authors believe protected the fly
from paraquat-induced oxidative damage. When they treated the
same flies with hydrogen peroxide, however, they found that the DJ-
1β mutants were extremely susceptible to early death. Min says this
suggests that DJ-1α and DJ-1β may normally protect cells against
different types of agents that promote oxidative stress.
Neither of the mutant DJ-1 fly strains will probably make an ideal
model for PD, according to Moore, because the flies don’t suffer from
the neurodegeneration seen in humans with DJ-1 mutations.
Nevertheless, says Bonini, studies of DJ-1 in Drosophila will provide
greater understanding of fundamental activities of the gene, helping to
elucidate how its function may be critical in PD. –Melissa Lee Phillips
PARKINSON DISEASE
ASTHMA
Asthma attacker? The drug etanercept
binds to TNF-α to block its action on the
immune system. The drug may be an effec-
tive treatment for severe asthma aggravated
by factors that affect immunity, such as virus-
es and air pollution. 
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New Guidelines for Pediatric
Asthma
More than 6 million U.S. children have asthma, the
leading cause of school absenteeism attributable to
chronic conditions and the third leading cause of
hospitalization among children under age 15. In
November 2005, the National Environmental
Education & Training
Foundation released
Environmental Manage-
ment of Pediatric
Asthma: Guidelines for
Healthcare Providers.
Funded by the NIEHS, the
peer-reviewed guidance
was built on current best
practices and includes
competencies for
managing environmental
asthma triggers in
pediatric care, an
environmental history
form for clinicians to use,
and intervention guidelines and fliers for specific
triggers such as dust mites, cockroaches, and mold
spores. Incorporating these guidelines into medical
and nursing curricula could give future generations
of primary care providers the tools to better
manage pediatric asthma.
Own Private Kyoto
Despite producing 24% of all greenhouse gas
emissions worldwide, the United States has not
signed on to the Kyoto Protocol to reduce
greenhouse gases. An analysis in the 17 November
2005 Nature shows, however, that as much as one-
third of the U.S. population lives in areas that have
adopted their own climate change abatement
policies. Together, these regions contribute almost
half of the U.S. GDP, a slightly larger share of the
global GDP than Japan, the world’s second largest
economy. The authors warn that compliance could
be challenging, though, especially since there are
currently no mechanisms for enforcement.
Software for Sorting Satellite
Images
NASA satellites generate enough data daily to fill
1,500 copies of the Encyclopedia Britannica, but
satellite data maps often have blank spots where a
satellite wasn’t able to record data on a particular
day. Now statis-
ticians at The Ohio
State University have
developed new
software that can
help researchers
rapidly process
incoming data to
produce complete,
detailed maps. In an
example given by
lead statistician Noel Cressie, it could take one
person 500 years to fill in the gaps in a map
depicting the thickness of the ozone layer, while
the same job would take three minutes with the
new software. The software also calculates a
measure of map precision. 
National Institute of Neurological
Disorders and Stroke
ehpnet
More than 600 disorders affect the nervous system, and neurologi-
cal disorders strike an estimated 50 million Americans annually. The
National Institute of Neurological Disorders and Stroke (NINDS) is
the NIH institute charged with overseeing research on these condi-
tions. The NINDS website at http://www.ninds.nih.gov/ provides the
latest news concerning the institute, its programs, and neurological
science in general, as well as a resource on the entire spectrum of
neurological diseases.
At the top of the homepage is a Disorder Index of the many
neurological conditions that the NINDS addresses. Selecting one of
the hundreds of disorders takes visitors to in-depth information
about the disorder’s symptoms, methods of diagnosis, treatment
options, research being done on the disorder, organizations devot-
ed to the disorder, related
NINDS publications (including
information in Spanish) and
additional resources from
MedlinePlus.
The site’s homepage fea-
tures the latest news about
neurological diseases, with
an archive of older items.
The homepage also includes
a section listing studies that are seeking subjects. Here, visitors can
learn more about what clinical trials really are; those who wish to
participate in a clinical trial can choose from an extensive list of neu-
rological conditions, from ADHD to Zellweger syndrome, to see
what research is in progress or coming up at the NINDS and else-
where across the country. 
Two sections of the homepage allow researchers to find out
about funding opportunities. Under the Funding Opportunities
header, visitors can retrieve lists of NINDS opportunities either for
the last 60 days or all current opportunities. This section also has
information on electronic submission of grant applications and
answers questions potential grantees may have about new govern-
ment requirements for submitting grant applications online. Under
the Funding Newsletters header, visitors can sign up for the free
NINDS Notes newsletter, published three times a year, which con-
tains information on grant applications, requests for applications,
and studies that need volunteers. The most current newsletter, plus
links to previous editions, are available on the site. 
The Neuroscience at NIH section of the homepage contains
three sections. The Research at NINDS (Intramural) section contains
links to information about NINDS faculty, research facilities, events,
and training programs such as summer programs and fellowships.
The NIH Blueprint section contains an overview of and link to an
NIH framework “to enhance cooperative activities among fifteen
NIH Institutes and Centers that support research on the nervous sys-
tem.” This section also has links to requests for information and
requests  for applications related to the blueprint. Finally,
the Neuroscience@NIH section contains information about NIH neu-
roscience faculty, areas of research interest, seminars, interest
groups, and postdoctoral openings. –Erin E. Dooley
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